Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Multinational Phase 3 Randomized Study to Evaluate the Safety and Efficacy of Treating Colorectal Cancer Patients With Recurrent Liver Metastases Using the Litx™ System Plus Chemotherapy as Compared to Chemotherapy Only

NCT00440310 is registered in ClinicalTrials.gov with Light Sciences Oncology as lead sponsor.

NCT NCT00440310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00440310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Multinational Phase 3 Randomized Study to Evaluate the Safety and Efficacy of Treating Colorectal Cancer Patients With Recurrent Liver Metastases Using the Litx™ System Plus Chemotherapy as Compared to Chemotherapy Only
Lead sponsor
Light Sciences Oncology
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
October 31, 2011
Enrollment
483 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms, liver metastases, neoplasm metastasis, neoplasm recurrence, local